Koesten Hirschmann & Crabtree’s DexCom DXCM Stock Holding History

Koesten Hirschmann & Crabtree’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1	Closed	-$100	–	95
2025 Q3	$100	Hold	1	–	–	﹤0.01%	247
2025 Q2	$129	Hold	1	–	–	﹤0.01%	321
2025 Q1	$101	Hold	1	–	–	﹤0.01%	205
2024 Q4	$115	Hold	1	–	–	﹤0.01%	192
2024 Q3	$99	Hold	1	–	–	﹤0.01%	194
2024 Q2	$205	Hold	1	–	–	﹤0.01%	210
2024 Q1	$205	Hold	1	–	–	﹤0.01%	210
2023 Q4	$183	Hold	1	–	–	﹤0.01%	174
2023 Q3	$138	Hold	1	–	–	﹤0.01%	172
2023 Q2	$190	Hold	1	–	–	﹤0.01%	160
2023 Q1	$172	Hold	1	–	–	﹤0.01%	245
2022 Q4	$167	Buy	+1	New	+$110	﹤0.01%	155

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Koesten Hirschmann & Crabtree's DXCM Position: Q4 2025 in Review

Koesten Hirschmann & Crabtree sold out of DexCom (DXCM) in Q4 2025, closing a stake of 1 share — an estimated $100 sold.

Koesten Hirschmann & Crabtree first reported a position in DXCM in Q4 2022 and held it in 12 quarters. The position peaked at $205 in Q2 2024. 922 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

Koesten Hirschmann & Crabtree reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
Koesten Hirschmann & Crabtree sold 1 DexCom share in Q4 2025, an estimated $100.
Koesten Hirschmann & Crabtree first reported a position in DexCom in Q4 2022 and held it in 12 quarters.
Koesten Hirschmann & Crabtree's DexCom position peaked at $205 in Q2 2024.
922 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Koesten Hirschmann & Crabtree's 13F filing for Q4 2025, filed 9 Feb 2026.